Who invested in HTG Molecular Diagnostics?
HTG Molecular Diagnostics's investors include SR One, Novo Holdings A/S, Fletcher Spaght, Inc., Sol Cap Inc and Merck.
United States · Funded startup
5 rounds we have observed, with the 5 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$47Mraised across 5 rounds since 2011, from 5 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
From a historical funding record
No investor was named in the report.
From a historical funding recordSEC filing: $7.5M sold, first sale Feb 2014
No investor was named in the report.
Reported by sec.govSEC filing: $7.6M sold, first sale Nov 2012
Reported by finsmes.comSEC filing: $14M sold, first sale Feb 2011
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
HTG Molecular Diagnostics's investors include SR One, Novo Holdings A/S, Fletcher Spaght, Inc., Sol Cap Inc and Merck.
HTG Molecular Diagnostics has raised $47M across 5 rounds since 2011.
HTG Molecular Diagnostics's most recent round was a Debt of $16M in Aug 2014.
Its most recent round, $16M in Aug 2014, is also its largest on record.
HTG Molecular Diagnostics's first round on record, in Feb 2011, was backed by Novo Holdings A/S, Fletcher Spaght, Inc. and Sol Cap Inc and 1 others.
HTG Molecular Diagnostics's latest named round is a Debt, in Aug 2014.
HTG Molecular Diagnostics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.